Back to Search
Start Over
929MO Platform study of neoadjuvant durvalumab (D) alone or combined with novel agents in patients (pts) with resectable, early-stage non-small cell lung cancer (NSCLC): Pharmacodynamic correlates and circulating tumor DNA (ctDNA) dynamics in the NeoCOAST study
- Source :
-
Annals of Oncology . 2022 Supplement 7, Vol. 33, pS971-S971. 1p. - Publication Year :
- 2022
- Subjects :
- *CIRCULATING tumor DNA
*NON-small-cell lung carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 33
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 159077844
- Full Text :
- https://doi.org/10.1016/j.annonc.2022.07.1055